User contributions
Jump to navigation
Jump to search
- 11:25, 23 October 2024 diff hist +6,448 N S100B Solution Levels Predict Treatment method Reaction throughout Individuals together with Melancholic Despression symptoms Created page with "Progression-free and overall survival at 18 months post-ASCT for each disease cohort were 85.7% and 100% for primary refractory DLBCL, 28.6% and 57.1% for relapsed DLBCL, not..." current